Litcius/Paper detail

Non-medical switch from the originator to biosimilar and between biosimilars of adalimumab in inflammatory bowel disease – a prospective, multicentre study

Livia Lontai, Lóránt Gönczi, F Balogh, Nóra Komlódi, Tamás Resál, Klaudia Farkas, Tamás Molnár, Pál Miheller, Petra A. Golovics, Eszter Schäfer, Tamás Szamosi, Ákos Iliás, Péter L. Lakatos

2022Digestive and Liver Disease17 citationsDOIOpen Access PDF

Topics & Concepts

BiosimilarMedicineAdalimumabInflammatory bowel diseaseIntensive care medicineDiseaseInternal medicineBiosimilars and Bioanalytical MethodsInflammatory Bowel DiseaseMicroscopic Colitis
Non-medical switch from the originator to biosimilar and between biosimilars of adalimumab in inflammatory bowel disease – a prospective, multicentre study | Litcius